Jim Simons Replimune Group, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 153,089 shares of REPL stock, worth $714,925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153,089
Previous 156,236
2.01%
Holding current value
$714,925
Previous $1.52 Million
6.63%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding REPL
# of Institutions
196Shares Held
77.6MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$51.6 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$50.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$22 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$21.8 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$18.3 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $230M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...